diosgenin has been researched along with palmitic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiang, CT; Lin, JK; Tsai, SJ; Way, TD | 1 |
Gao, X; Huang, F; Kou, J; Liu, B; Liu, K; Zhao, W | 1 |
Chen, G; Dong, H; Fang, K; Li, J; Lu, F; Wu, F; Xu, L; Zhao, Y; Zou, X | 1 |
3 other study(ies) available for diosgenin and palmitic acid
Article | Year |
---|---|
Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diosgenin; Down-Regulation; Drug Screening Assays, Antitumor; Fatty Acid Synthases; Humans; JNK Mitogen-Activated Protein Kinases; Palmitic Acid; Phosphoproteins; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Solanaceous Alkaloids; Tomatine; TOR Serine-Threonine Kinases; Up-Regulation | 2007 |
Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cells, Cultured; Diosgenin; Dose-Response Relationship, Drug; Endothelin-1; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Human Umbilical Vein Endothelial Cells; Humans; I-kappa B Kinase; Inflammation Mediators; Insulin Receptor Substrate Proteins; Insulin Resistance; Interleukin-6; Microscopy, Fluorescence; Nitric Oxide; Nitric Oxide Synthase Type III; Palmitic Acid; Phosphorylation; Plasminogen Activator Inhibitor 1; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Salicylic Acid; Signal Transduction; Tumor Necrosis Factor-alpha; Vasodilation | 2012 |
Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Carnitine O-Acetyltransferase; Cell Line; Diosgenin; Fatty Acid Synthases; Humans; Lipid Metabolism; Liver; Non-alcoholic Fatty Liver Disease; Palmitic Acid; Signal Transduction; Sterol Regulatory Element Binding Protein 1 | 2019 |